Skip to Main Content

Paper Details

Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality.
Transplant Cell Ther
18
2022
Allogeneic Stem Cell, CMV, CMV infection, CMV viremia, Cancer, IgG, Letermovir, MMUD, PTCy, Patients, T-cell-, T-cell-depleted grafts, cyclophosphamide, cytomegalovirus, graft-versus-host, letermovir, patients, prednisone, steroid
Author NameAffiliation
Peter WesterveltSiteman Cancer Center
Ravi VijSiteman Cancer Center
  • 1 - 2

Datasets

Release 1.2